Search research articles
Contact Us
Filters
Showing results (561-570 of 1,184) with videos related to
Page
of 119
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes
Jose Yuste, Sifot Ali, Shiranee Sriskandan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 1, 1991
Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease
J S Hyams, W R Treem, E Eddy, et al.
The Journal of Biological Chemistry
|
October 5, 1991
Use of a heat-stable microtubule-associated protein class-specific antibody to investigate the mechanism of microtubule binding
J Dingus, R A Obar, J S Hyams, et al.
Pediatrics
|
January 26, 1999
Intractable diarrhea from cytomegalovirus enterocolitis in an immunocompetent infant
L M Fox, M A Gerber, L Penix, et al.
Journal of Endourology
|
January 22, 2024
Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical Prostatectomy in Contemporary National Surgical Quality Improvement Program Data
Alexander Homer, Borivoj Golijanin, Phillip Schmitt, et al.
Frontiers in Microbiology
|
June 16, 2023
Physiological changes during torpor favor association with <i>Endozoicomonas</i> endosymbionts in the urochordate <i>Botrylloides leachii</i>
Yosef Hyams, Maxim Rubin-Blum, Amalia Rosner, et al.
Gastroenterology
|
May 1, 1993
Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease
J S Hyams, J E Fitzgerald, W R Treem, et al.
The Journal of Pediatrics
|
July 1, 1996
Clinical outcome of ulcerative colitis in children
J S Hyams, P Davis, K Grancher, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Epidemiology (Cambridge, Mass.)
|
March 15, 2001
Population factors not addressed in cohort study
S Woodward, J Hyams, L Tanner, et al.
Page
of 119
Search research articles
Search
Showing results (561-570 of 1,184) with videos related to
Sort By:
Page
of 119
Journal of Immunology (Baltimore, Md. : 1950)
|
May 4, 2006
Roles of the alternative complement pathway and C1q during innate immunity to Streptococcus pyogenes
Jose Yuste, Sifot Ali, Shiranee Sriskandan, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
February 1, 1991
Tumor necrosis factor-alpha is not elevated in children with inflammatory bowel disease
J S Hyams, W R Treem, E Eddy, et al.
The Journal of Biological Chemistry
|
October 5, 1991
Use of a heat-stable microtubule-associated protein class-specific antibody to investigate the mechanism of microtubule binding
J Dingus, R A Obar, J S Hyams, et al.
Pediatrics
|
January 26, 1999
Intractable diarrhea from cytomegalovirus enterocolitis in an immunocompetent infant
L M Fox, M A Gerber, L Penix, et al.
Journal of Endourology
|
January 22, 2024
Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical Prostatectomy in Contemporary National Surgical Quality Improvement Program Data
Alexander Homer, Borivoj Golijanin, Phillip Schmitt, et al.
Frontiers in Microbiology
|
June 16, 2023
Physiological changes during torpor favor association with <i>Endozoicomonas</i> endosymbionts in the urochordate <i>Botrylloides leachii</i>
Yosef Hyams, Maxim Rubin-Blum, Amalia Rosner, et al.
Gastroenterology
|
May 1, 1993
Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease
J S Hyams, J E Fitzgerald, W R Treem, et al.
The Journal of Pediatrics
|
July 1, 1996
Clinical outcome of ulcerative colitis in children
J S Hyams, P Davis, K Grancher, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
June 24, 2018
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
Constantin A Dasanu, Michael Del Rosario, Ion Codreanu, et al.
Epidemiology (Cambridge, Mass.)
|
March 15, 2001
Population factors not addressed in cohort study
S Woodward, J Hyams, L Tanner, et al.
Page
of 119